Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]British Columbia Cancer Agency"
Count: 168
Selected: 0
| NCT ID | Title |
|---|
| NCT05132244 | Monitoring and Managing Glucose Levels in People With Pancreatic Cancer | ||
| NCT04141397 | Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care | ||
| NCT02808884 | Cancer DNA Screening Pilot Study (CANDACE) | ||
| NCT03202810 | Innovative Approach to Triage Oral Precancer | ||
| NCT02847767 | Dynamic Contrast Enhanced HCC SABR Liver Study | ||
| NCT03450018 | A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX | ||
| NCT03862911 | Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | ||
| NCT02869802 | Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | ||
| NCT05025878 | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. | ||
| NCT04915144 | 177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs | ||
| NCT05057234 | PRecision Oncology Evidence Development in Cancer Treatment - Liquid | ||
| NCT05257967 | CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease | ||
| NCT04015622 | PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA | ||
| NCT04273061 | Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity | ||
| NCT05373251 | PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer | ||
| NCT03694015 | SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases | ||
| NCT02933242 | Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases | ||
| NCT04495959 | Dynamic Whole Body PET/ MRI | ||
| NCT04610372 | 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | ||
| NCT02297672 | Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant | ||
| NCT04705649 | Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer | ||
| NCT02692105 | Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer | ||
| NCT02431715 | 18F-FDOPA PET in Neuroendocrine Tumours | ||
| NCT02660788 | A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women | ||
| NCT01881451 | Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer | ||
| NCT04484701 | [68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer | ||
| NCT03583528 | DOTATOC PET/CT for Imaging NET Patients | ||
| NCT01764191 | 18F-FDG PET Imaging in Cardiac Sarcoidosis | ||
| NCT04257396 | Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy | ||
| NCT04831307 | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical | ||
| NCT03693742 | MSG Use With 18F-DCFPyL PET/CT Imaging | ||
| NCT02899312 | PSMA PET/CT for Assessment of Recurrent Prostate Cancer | ||
| NCT00816582 | PET/CT Guided Fulvestrant Therapy for Patients With Recurrent or Metastatic Breast Cancer | ||
| NCT05050929 | RAPid SimPLE Targeted Radiation Treatment for Brain Metastases | ||
| NCT01046123 | Volumetric Modulated Arc Therapy (VMAT) for Brain Metastases | ||
| NCT01772498 | HRV Biofeedback for Brain Tumour Survivors | ||
| NCT02108613 | Living Well on Androgen Deprivation Therapy | ||
| NCT00324467 | Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment | ||
| NCT04787289 | A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer | ||
| NCT01605097 | High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule | ||
| NCT04814095 | PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc | ||
| NCT02155621 | Personalized Oncogenomics (POG) Program of British Columbia | ||
| NCT03246802 | Partial Prostate Salvage High Dose Rate Brachytherapy | ||
| NCT03917082 | Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer | ||
| NCT03426748 | LDR vs. HDR Brachytherapy for Prostate Cancer | ||
| NCT04543851 | CARA Treatment Pilot Study for Breast Positioning | ||
| NCT03769103 | Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC | ||
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | ||
| NCT04714333 | Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath | ||
| NCT04207762 | 18F-AmBF3-TATE PET/CT for Imaging NET Patients |
